-
RARE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ultragenyx Pharmaceutical (RARE)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 184.16 mm | 184.16 mm | 184.16 mm | 184.16 mm | 184.16 mm | 184.16 mm |
Cash burn (monthly) | (no burn) | (no burn) | 44.47 mm | 43.69 mm | 26.50 mm | 19.20 mm |
Cash used (since last report) | n/a | n/a | 76.51 mm | 75.17 mm | 45.60 mm | 33.04 mm |
Cash remaining | n/a | n/a | 107.65 mm | 108.99 mm | 138.56 mm | 151.12 mm |
Runway (months of cash) | n/a | n/a | 2.4 | 2.5 | 5.2 | 7.9 |
13F holders | Current |
---|---|
Total holders | 311 |
Opened positions | 55 |
Closed positions | 45 |
Increased positions | 111 |
Reduced positions | 108 |
13F shares | Current |
---|---|
Total value | 3.47 tn |
Total shares | 87.35 mm |
Total puts | 845.52 k |
Total calls | 666.46 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 10.03 mm | $422.17 bn |
BlackRock | 6.54 mm | $274.99 bn |
Sands Capital Management | 4.30 mm | $180.82 bn |
STT State Street | 2.72 mm | $114.54 bn |
T. Rowe Price | 2.51 mm | $105.70 mm |
Wellington Management | 2.46 mm | $103.39 bn |
Clearbridge Advisors | 2.32 mm | $97.70 bn |
FHI Federated Hermes | 2.05 mm | $86.24 bn |
RTW Investments | 1.97 mm | $82.79 bn |
Rock Springs Capital Management | 1.74 mm | $73.19 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Dec 24 | Emil D Kakkis | Common Stock | Sell | Dispose S | Yes | No | 42.23 | 11,727 | 495.23 k | 2,183,985 |
10 Dec 24 | Theodore Alan Huizenga | Common Stock | Gift | Dispose G | No | No | 0 | 648 | 0.00 | 41,840 |
10 Dec 24 | Emil D Kakkis | Common Stock | Sell | Dispose S | Yes | No | 50 | 8,273 | 413.65 k | 2,195,712 |
9 Dec 24 | Emil D Kakkis | Common Stock | Gift | Dispose G | Yes | No | 0 | 20,000 | 0.00 | 2,203,985 |
10 Oct 24 | Horn Howard | Common Stock | Sell | Dispose S | No | No | 52.76 | 7,465 | 393.85 k | 92,301 |
16 Sep 24 | Theodore Alan Huizenga | Common Stock | Grant | Acquire A | No | No | 0 | 700 | 0.00 | 42,251 |